Scott R. Rudge, PhD RMC Pharmaceutical Solutions Inc.

Dr. Rudge is a founder, COO and Chairman with RMC Pharmaceutical Solutions Inc. RMC Pharmaceutical Solutions is a privately held, internationally recognized expert services consultancy focusing on manufacturing and quality issues in the pharmaceutical, biotechnology, medical device and nutraceutical industries. He also serves as Sr. Vice President and Co-founder of Margaux Biologics, a start-up biotechnology company focused on the commercialization of hematological products. He previously served in a similar role for Bradmer Pharmaceuticals, a start-up biotechnology company developing targeted radiolabeled antibodies for the treatment of glioblastoma multiforme. In his last real job, Dr. Rudge was Vice President of Operations with FeRx Inc., a magnetic drug delivery research and development company. Prior to his seven years with FeRx, Dr. Rudge held positions in Process Development and Process Engineering with Amylin and Synergen, and as a Staff Scientist with the National Institute of Standards and Technology. Dr. Rudge serves as an Adjunct Professor of Chemical Engineering at the University of Colorado, where he teaches courses in bioprocessing and bioseparations, and supervises graduate students. Dr. Rudge received his undergraduate degree at Worcester Polytechnic Institute and his Masters and Doctorate degrees in Chemical Engineering at Purdue University. He is the co-author of a bestselling text book on bioseparations and engineering entitled “Bioseparation Science and Engineering” (Oxford Press), and has sixteen other scholarly publications. Dr. Rudge serves on the senior advisory board to Interphex, and as an editor for BMC Biotechnology.